Virtu Financial LLC Biotechnology

Virtu Financial LLC

$1.89 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
RANI Rani Therapeutics Holdings, Inc.	$37.5M	$62,000 0.0% of portfolio	45,404	Q4 2024 New
RLAY Relay Therapeutics, Inc.	$410M	$62,000 0.0% of portfolio	15,046	Q4 2024 Reduced 67.99%
VOR Vor Biopharma Inc.	$41.1M	$60,000 0.0% of portfolio	54,470	Q4 2024 New
CTMX Cytom X Therapeutics, Inc.	$44.8M	$59,000 0.0% of portfolio	57,012	Q4 2024 Reduced 35.59%
XBIT X Biotech Inc.	$107M	$58,000 0.0% of portfolio	14,735	Q4 2024 New
XERS Xeris Biopharma Holdings, Inc.	$521M	$58,000 0.0% of portfolio	17,137	Q4 2024 New
CGTX Cognition Therapeutics Inc	$10.2M	$56,000 0.0% of portfolio	80,180	Q4 2024 Added 40.1%
CRTX Cortexyme, Inc.	$70.5M	$55,000 0.0% of portfolio	29,204	Q4 2024 New
SAVA Cassava Sciences Inc	$96.2M	$51,000 0.0% of portfolio	21,807	Q4 2024 New
SPRO Spero Therapeutics, Inc.	$27.4M	$47,000 0.0% of portfolio	46,046	Q4 2024 New
SLS Sellas Life Sciences Group, Inc.	$24.3M	$43,000 0.0% of portfolio	41,155	Q4 2024 Reduced 48.06%
ELEV Elevation Oncology, Inc.	$12.1M	$36,000 0.0% of portfolio	63,974	Q4 2024 New
TPST Tempest Therapeutics, Inc.	$8.44M	$36,000 0.0% of portfolio	43,105	Q4 2024 New
OCGN Ocugen, Inc.	$141M	$32,000 0.0% of portfolio	39,322	Q4 2024 New
STTK Shattuck Labs, Inc.	$55.9M	$30,000 0.0% of portfolio	24,446	Q4 2024 New
ACET Adicet Bio, Inc.	$36M	$29,000 0.0% of portfolio	30,611	Q4 2024 New
NAUT Nautilus Biotechnology, Inc.	$162M	$28,000 0.0% of portfolio	16,604	Q4 2024 New
CMMB Chemomab Therapeutics Ltd.	$19.2M	$26,000 0.0% of portfolio	14,445	Q4 2024 New
ALLK Allakos Inc.	$23.7M	$25,000 0.0% of portfolio	20,274	Q4 2024 New
ACXP Acurx Pharmaceuticals, Inc.	$8.21M	$23,000 0.0% of portfolio	27,836	Q4 2024 New
ELYM Eliem Therapeutics, Inc.	$109M	$21,000 0.0% of portfolio	11,733	Q4 2024 New
VIRX Viracta Therapeutics, Inc.	$751K	$21,000 0.0% of portfolio	128,231	Q4 2024 New
ALVR Allovir, Inc.	$912M	$20,000 0.0% of portfolio	46,576	Q4 2024 New
LVTX Lava Therapeutics Nv	$33.3M	$19,000 0.0% of portfolio	19,916	Q4 2024 Added 4.26%
APLT Applied Therapeutics Inc.	$24.5M	$18,000 0.0% of portfolio	21,414	Q4 2024 New
CUE Cue Biopharma, Inc.	$43.5M	$18,000 0.0% of portfolio	16,829	Q4 2024 New
NXTC Next Cure, Inc.	$21.6M	$18,000 0.0% of portfolio	22,951	Q4 2024 New
BOLT Bolt Biotherapeutics, Inc.	$17.7M	$16,000 0.0% of portfolio	29,552	Q4 2024 New
ADGI Adagio Therapeutics, Inc.	$505M	$14,000 0.0% of portfolio	30,970	Q4 2024 New
CLSD Clearside Biomedical, Inc.	$53M	$13,000 0.0% of portfolio	13,505	Q4 2024 New
CNTX Context Therapeutics Inc.	$14.2M	$12,000 0.0% of portfolio	11,638	Q4 2024 New
EQ Equillium, Inc.	$26.1M	$12,000 0.0% of portfolio	15,689	Q4 2024 Added 10.86%
IMUX Immunic, Inc.	$36.4M	$12,000 0.0% of portfolio	12,128	Q4 2024 Reduced 60.05%
SLGL Sol Gel Technologies Ltd.	$15.5M	$12,000 0.0% of portfolio	13,343	Q4 2024 New
IPA Immuno Precise Antibodies Ltd.	$8.44M	$9,000 0.0% of portfolio	20,759	Q4 2024 New
LYRA Lyra Therapeutics, Inc.	$6.68M	$9,000 0.0% of portfolio	42,069	Q4 2024 New
SILO Silo Pharma, Inc.	$4.27M	$9,000 0.0% of portfolio	10,430	Q4 2024 Reduced 59.28%
VRCA Verrica Pharmaceuticals Inc.	$327M	$9,000 0.0% of portfolio	13,047	Q4 2024 New
AIM Aim Immuno Tech Inc.	$6.73M	$7,000 0.0% of portfolio	36,658	Q4 2024 Reduced 64.11%
HCWB Hcw Biologics Inc.	$13.6M	$7,000 0.0% of portfolio	15,623	Q4 2024 New
BTAI Bio Xcel Therapeutics, Inc.	$60.5M	$6,000 0.0% of portfolio	16,983	Q4 2024 New
INAB In8 Bio, Inc.	$6.62M	$6,000 0.0% of portfolio	21,990	Q4 2024 Reduced 58.36%
PASG Passage Bio, Inc.	$28.3M	$6,000 0.0% of portfolio	10,286	Q4 2024 New
NRXPW Nrx Pharmaceuticals Inc Wt Exp	$0	$4,000 0.0% of portfolio	25,516	Q4 2024 Reduced 26.44%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.